Twenty new 4,4′‐dibenzoyl‐1,1′‐dibenzyl‐1,1′‐(decane‐1,5‐diyl)‐piperazinium dihalides 5a‐l and 1,1prime;‐dibenzyl‐1,1′‐(decane‐1,5‐diyl) piperazinium dihydrochloride dihalides 6a‐l were prepared and evaluated for their analgesic, sedative and anti‐inflammatory activities. Structure‐activity relationship studies indicated that the compounds 6c (Ar = 4‐NO2C6H5) and 6k (Ar = 3‐Me‐C6H5) exhibited higher
20个新的4,4'-二苯甲酰基-1,1'-二苄基-1,1'-(
癸烷-1,5-二基)-
哌嗪鎓二卤化物5a-l和1,1prime;-二苄基-1,1'-(制备
癸烷 - 1,5 - 二基)
哌嗪二盐酸盐二卤化物 6a - l 并评估其镇痛、镇静和抗炎活性。构效关系研究表明化合物6c(Ar=4-NO2 )和6k(Ar=3-Me-
C6H5)比其他化合物表现出更高的活性。与相应的化合物6k和6l相比,化合物5k和5l中苯甲酰基的存在对活性产生相反的影响。5h 和 6h 分别在系列 5 和 6 中显示出最高的抗炎活性(59%,剂量 20 mg/kg 和 48%,剂量 1 mg/kg)。